Multiply Labs
CA - San FranciscoBiotechnology
Focus: Multiply Labs is an early-stage robotics company focused on automating cell therapy manufacturing for gene and cell therapies. Founded in 2022 and headquartered in San Francisco, the company operates at the intersection of biotech and advanced manufacturing.
Profile data last refreshed 55m ago · AI intelligence enriched 3w ago
Open Jobs
6-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Multiply Labs?
AI assessmentBest suited for engineers and technologists who thrive in early-stage, capital-intensive hardware-software startups where execution risk is high but upside is uncapped.
Why Work Here
- You'll work on cutting-edge robotics automation for an underserved manufacturing bottleneck in cell therapy, a high-growth therapeutic area.
- Recent AstraZeneca collaboration (January 2026) signals validation and near-term revenue/partnership opportunities for a 4-year-old company.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Multiply Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.